Meta Biomed Co., Ltd. (KOSDAQ:059210)
South Korea
· Delayed Price · Currency is KRW 5,340.00
+60.00 (1.14%)
At close: May 13, 2025, 3:30 PM KST
Meta Biomed Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 22,402 | 10,080 | 2,628 | 9,522 | -4,093 | Upgrade
|
| Depreciation & Amortization | 4,981 | 4,223 | 3,860 | 3,571 | 3,941 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.91 | -12.62 | -1,212 | -1,160 | 95.87 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 1,015 | 487.37 | 541.23 | 4,661 | Upgrade
|
| Loss (Gain) From Sale of Investments | -349.53 | -90.29 | -53.65 | -51.16 | 260.6 | Upgrade
|
| Loss (Gain) on Equity Investments | -1,181 | -682.88 | -373.09 | -537.62 | -468.69 | Upgrade
|
| Provision & Write-off of Bad Debts | 444.66 | -158.44 | -172.39 | -1,376 | 8.39 | Upgrade
|
| Other Operating Activities | -1,451 | -2,926 | 2,115 | -1,637 | 57.12 | Upgrade
|
| Change in Accounts Receivable | 593.08 | 186.61 | -1,024 | -171.24 | 2,190 | Upgrade
|
| Change in Inventory | -2,514 | -470.44 | 926.99 | 2,038 | -1,989 | Upgrade
|
| Change in Accounts Payable | -807.66 | 304.05 | 93.14 | -1,503 | -513.05 | Upgrade
|
| Change in Other Net Operating Assets | 513.17 | -1,251 | 1,884 | 1,900 | 712 | Upgrade
|
| Operating Cash Flow | 22,633 | 10,217 | 9,159 | 11,136 | 4,862 | Upgrade
|
| Operating Cash Flow Growth | 121.52% | 11.55% | -17.75% | 129.06% | 69.70% | Upgrade
|
| Capital Expenditures | -10,914 | -11,489 | -15,395 | -2,067 | -2,227 | Upgrade
|
| Sale of Property, Plant & Equipment | 61.83 | 128.06 | 7.45 | 1,413 | 6.53 | Upgrade
|
| Cash Acquisitions | - | - | -2,295 | -2.45 | - | Upgrade
|
| Divestitures | - | - | - | 535.01 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -188.9 | -5.43 | 85.95 | -33.29 | -824.5 | Upgrade
|
| Investment in Securities | -32,421 | 1,116 | -167.9 | 6,349 | -7,464 | Upgrade
|
| Other Investing Activities | 98.4 | -1,451 | 3,186 | 130 | 593.94 | Upgrade
|
| Investing Cash Flow | -43,363 | -11,701 | -14,578 | 6,324 | -9,915 | Upgrade
|
| Long-Term Debt Issued | 60,700 | 11,375 | 37,083 | 1,949 | 16,759 | Upgrade
|
| Long-Term Debt Repaid | -36,544 | -11,940 | -27,828 | -17,827 | -5,123 | Upgrade
|
| Net Debt Issued (Repaid) | 24,156 | -565.37 | 9,255 | -15,878 | 11,635 | Upgrade
|
| Repurchase of Common Stock | -140.74 | - | -63.26 | - | - | Upgrade
|
| Dividends Paid | -457.42 | -457.42 | -458.02 | -229.01 | -232.67 | Upgrade
|
| Other Financing Activities | -148 | -0 | - | 0 | 0 | Upgrade
|
| Financing Cash Flow | 23,410 | -1,023 | 8,734 | -16,107 | 11,403 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1,041 | 77.02 | -201.36 | 121.38 | -60.48 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | - | -0 | 0 | - | Upgrade
|
| Net Cash Flow | 3,721 | -2,430 | 3,113 | 1,474 | 6,288 | Upgrade
|
| Free Cash Flow | 11,719 | -1,271 | -6,236 | 9,069 | 2,634 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 244.28% | - | Upgrade
|
| Free Cash Flow Margin | 12.46% | -1.53% | -9.04% | 15.43% | 5.85% | Upgrade
|
| Free Cash Flow Per Share | 432.22 | -55.59 | -272.48 | 396.00 | 114.32 | Upgrade
|
| Cash Interest Paid | 2,094 | 2,176 | 1,259 | 733.31 | 1,278 | Upgrade
|
| Cash Income Tax Paid | 163.57 | 80 | 379.03 | 357.43 | 293.62 | Upgrade
|
| Levered Free Cash Flow | 6,742 | -3,338 | -6,175 | 5,650 | 1,895 | Upgrade
|
| Unlevered Free Cash Flow | 9,081 | -1,891 | -5,306 | 6,366 | 2,527 | Upgrade
|
| Change in Net Working Capital | -4,439 | 1,246 | -2,790 | -1,607 | -66.21 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.